Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Bunse

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|January 8, 2025
Heating Up IDH-Mutant GliomasMichael Platten, Lukas Bunse
Neuro-Oncology|December 17, 2021
How mutant isocitrate dehydrogenase orchestrates immune cellsLukas Bunse, Michael Platten
Cancer Cell|May 31, 2024
Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune systemNikolas Layer, Lukas Bunse, Varun Venkataramani
Methods in Enzymology|November 16, 2019
High-throughput discovery of cancer-targeting TCRsLukas Bunse, Edward W Green, Michael Platten
Current Opinion in Oncology|August 14, 2018
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomasMirco Friedrich, Lukas Bunse, Wolfgang Wick, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2016
Concepts in glioma immunotherapyMichael Platten, Lukas Bunse, Wolfgang Wick, et al.
Oncoimmunology|May 13, 2015
Mutant IDH1: An immunotherapeutic target in tumorsTheresa Schumacher, Lukas Bunse, Wolfgang Wick, et al.
Current Opinion in Neurology|October 7, 2017
The promises of immunotherapy in gliomasIris Mildenberger, Lukas Bunse, Katharina Ochs, et al.
Current Opinion in Biotechnology|July 29, 2023
2-hydroxyglutarate rides the cancer-immunity cycleIosifina P Foskolou, Lukas Bunse, Jan Van den Bossche
Biomedicines|July 27, 2022
Site-Specific Considerations on Engineered T Cells for Malignant GliomasNirmeen Elmadany, Obada T Alhalabi, Michael Platten, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|January 8, 2025
Heating Up IDH-Mutant GliomasMichael Platten, Lukas Bunse
Neuro-Oncology|December 17, 2021
How mutant isocitrate dehydrogenase orchestrates immune cellsLukas Bunse, Michael Platten
Cancer Cell|May 31, 2024
Neural deception: Breast cancer co-opts neuronal mechanisms to evade the immune systemNikolas Layer, Lukas Bunse, Varun Venkataramani
Methods in Enzymology|November 16, 2019
High-throughput discovery of cancer-targeting TCRsLukas Bunse, Edward W Green, Michael Platten
Current Opinion in Oncology|August 14, 2018
Perspectives of immunotherapy in isocitrate dehydrogenase-mutant gliomasMirco Friedrich, Lukas Bunse, Wolfgang Wick, et al.
Cancer Immunology, Immunotherapy : CII|July 28, 2016
Concepts in glioma immunotherapyMichael Platten, Lukas Bunse, Wolfgang Wick, et al.
Oncoimmunology|May 13, 2015
Mutant IDH1: An immunotherapeutic target in tumorsTheresa Schumacher, Lukas Bunse, Wolfgang Wick, et al.
Current Opinion in Neurology|October 7, 2017
The promises of immunotherapy in gliomasIris Mildenberger, Lukas Bunse, Katharina Ochs, et al.
Current Opinion in Biotechnology|July 29, 2023
2-hydroxyglutarate rides the cancer-immunity cycleIosifina P Foskolou, Lukas Bunse, Jan Van den Bossche
Biomedicines|July 27, 2022
Site-Specific Considerations on Engineered T Cells for Malignant GliomasNirmeen Elmadany, Obada T Alhalabi, Michael Platten, et al.
Pageof 7